How has been the historical performance of the Ventive Hospital?

Jun 07 2025 01:11 AM IST
share
Share Via
Ventive Hospital experienced significant revenue growth from Rs 477.98 crore to Rs 1,604.71 crore in the fiscal year ending March 2025, but faced challenges with profitability metrics, including a decrease in consolidated net profit and earnings per share. Total assets and cash flow improved, indicating a strong asset base despite rising liabilities.
Answer:
The historical performance of Ventive Hospital shows significant growth in its financial metrics from Mar'24 to Mar'25.

Breakdown:
In the fiscal year ending March 2025, Ventive Hospital reported net sales of Rs 1,604.71 crore, a substantial increase from Rs 477.98 crore in the previous year. Total operating income mirrored this growth, reaching Rs 1,604.71 crore, while total expenditure, excluding depreciation, rose to Rs 843.88 crore from Rs 194.15 crore. The operating profit (PBDIT) increased to Rs 828.65 crore, up from Rs 300.56 crore, reflecting a decrease in operating profit margin from 59.38% to 47.41%. Profit before tax also saw an increase to Rs 309.65 crore from Rs 205.19 crore, with profit after tax rising to Rs 181.03 crore compared to Rs 166.32 crore the previous year. However, consolidated net profit decreased to Rs 120.29 crore from Rs 166.32 crore, influenced by share in profit of associates and minority interest. The earnings per share (EPS) dropped significantly to Rs 5.15 from Rs 159.31, while the PAT margin fell to 10.29% from 34.8%. On the balance sheet, total liabilities increased to Rs 951.97 crore from Rs 779.29 crore, with total debt slightly decreasing to Rs 412.61 crore. The total assets also rose to Rs 951.97 crore from Rs 779.29 crore, indicating a robust asset base. Cash flow from operating activities improved to Rs 265.00 crore from Rs 215.00 crore, contributing to a net cash inflow of Rs 9.00 crore, up from Rs 6.00 crore. Overall, while Ventive Hospital demonstrated strong revenue growth, challenges in profitability metrics and net profit indicate areas for further analysis.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News